Crown Holdings Reports Q1 GAAP EPS Decline and Negative Operating Cash Flow
Summary
Crown Holdings reported a decline in GAAP diluted EPS and a shift to negative operating cash flow for Q1 2026, despite ongoing share repurchases and significant capital investments.
Key Events
-
Q1 GAAP EPS Decline
Diluted EPS decreased to $1.56 for Q1 2026, down from $1.65 in Q1 2025.
-
Negative Operating Cash Flow
Cash flow from operating activities shifted to a $54 million outflow in Q1 2026, compared to a $14 million inflow in the prior year.
-
Increased Capital Expenditures
Capital spending rose to $87 million in Q1 2026 from $33 million in Q1 2025, with $550 million projected for the full year to support growth.
-
Share Repurchases Continue
The company repurchased $212 million in common stock during Q1 2026, with approximately $1.1 billion remaining under the current authorization.
Analysis
This quarterly report provides detailed financial results for Q1 2026, revealing a decrease in GAAP diluted earnings per share to $1.56 from $1.65 in the prior year, contrasting with the "strong adjusted EPS" highlighted in the recent 8-K. A notable concern is the shift in cash flow from operating activities, moving from a $14 million inflow in Q1 2025 to a $54 million outflow in Q1 2026, indicating increased working capital usage. The company continued its share repurchase program, buying back $212 million in stock, with approximately $1.1 billion remaining under the authorization. Long-term debt also increased by $296 million, partly due to drawing on revolving credit facilities to fund operations and increased capital expenditures, which rose to $87 million in the quarter and are projected at $550 million for the full year to support growth initiatives. Investors should monitor the company's ability to reverse the negative operating cash flow trend and the impact of increased debt on its balance sheet.
At the time of this filing, CCK was trading at $100.32 on NYSE in the Manufacturing sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $89.21 to $116.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.